Vimarsana
Biggest News Aggregation in the World

Arnuity Ellipta News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Arnuity Ellipta. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Arnuity Ellipta Today - Breaking & Trending Today

Blue Cross and Blue Shield of Alabama announces cost reduction of asthma inhalers, insulin treatments - Vimarsana News

Blue Cross and Blue Shield of Alabama announces cost reduction of asthma inhalers, insulin treatments

Blue Cross and Blue Shield of Alabama has announced that it will be reducing the copay on Novolog insulin, Asmanex inhalers, Arnuity Ellipta inhalers, and QVAR RediHalers. The insurance company said that it wants to help alleviate financial burdens and make the products more readily available at lower prices for members.

Biden Administration Extends Efforts for $35 Monthly Asthma Inhaler Price Cap - Vimarsana News

Biden Administration Extends Efforts for $35 Monthly Asthma Inhaler Price Cap

President Joe Biden and Senator Bernie Sanders continue their push to cut the cost of asthma inhalers and prescription drugs in the US.

Source: ajmc.com
Are Your Patients Prepared to Switch Their Asthma Inhaler? - Vimarsana News

Are Your Patients Prepared to Switch Their Asthma Inhaler?

With the discontinuation of Flovent, we must prevent gaps in care

Popular asthma inhaler is now discontinued — what does that mean for patients? - Vimarsana News

Popular asthma inhaler is now discontinued — what does that mean for patients?

Glaxo Smith Kline (GSK) announced in May that Flovent HFA, a metered-dose inhaler, as well as Flovent Diskus, a dry powder inhaler, would be discontinued as of Dec. 31, 2023. Experts shared comment.

Popular asthma inhaler no longer available, leaving patients scrambling - Vimarsana News

Popular asthma inhaler no longer available, leaving patients scrambling

Flovent, a popular corticosteroid inhaler used to treat asthma, is no longer available.

Source: nypost.com